Diuretics Flashcards
loop diuretic effects on acid/base
thiazide and loop diuretics induce metabolic alkalosis in three ways: 1. hypovolemia -> incr Na reabs in PT via Na-H exchanger due to incr AgII (leading to more bicarb reabs), 2. hypovolemia -> hyperaldo -> three mechs -> alkalosis, 3. these diuretics cause more Na in distal tubule, where Na enters principal cell and causes negative lumen V which incr H+/K+ secr
thiazide diuretic effects on acid/base
thiazide and loop diuretics induce metabolic alkalosis in three ways: 1. hypovolemia -> incr Na reabs in PT via Na-H exchanger due to incr AgII (leading to more bicarb reabs), 2. hypovolemia -> hyperaldo -> three mechs -> alkalosis, 3. these diuretics cause more Na in distal tubule, where Na enters principal cell and causes negative lumen V which incr H+/K+ secr
osmotic diuretic effects on acid/base
osmotic diuretics induce metabolic acidosis (bicarb excreted via solvent drag?)
CA inhibitor effects on acid/base
CA inhibitors induce metabolic acidosis (more bicarb excretion)
K-sparing diuretics effects on acid/base
K-sparing diuretics induce metabolic acidosis (Na not reabsorbed, therefore lumen not negative, therefore H+ not excreted)
effects on acid-base by: osmotic diuretics, CAI, loop diuretics, thiazides, K sparing diuretics
thiazide and loop diuretics induce metabolic alkalosis in three ways: 1. hypovolemia -> incr Na reabs in PT via Na-H exchanger due to incr AgII (leading to more bicarb reabs), 2. hypovolemia -> hyperaldo -> three mechs -> alkalosis, 3. these diuretics cause more Na in distal tubule, where Na enters principal cell and causes negative lumen V which incr H+/K+ secr; CA inhibitors induce metabolic acidosis (more bicarb excretion); osmotic diuretics induce metabolic acidosis (bicarb excreted via solvent drag?); K-sparing diuretics induce metabolic acidosis (Na not reabsorbed, therefore lumen not negative, therefore H+ not excreted)
loop diuretic effects on K
loop/thiazide diuretic cause V depletion (-> aldo) and incr distal Na delivery (inhibit TAL/DCT Na reabs) -> incr K secretion -> hypokalemia; also cause alkalosis -> hypokalemia; thiazide are more kaliuretic than loop b/c they have longer DOA and thus less likely to have K conserving time periods
thiazide diuretic effects on K
loop/thiazide diuretic cause V depletion (-> aldo) and incr distal Na delivery (inhibit TAL/DCT Na reabs) -> incr K secretion -> hypokalemia; also cause alkalosis -> hypokalemia; thiazide are more kaliuretic than loop b/c they have longer DOA and thus less likely to have K conserving time periods
osmotic diuretic effects on K
osmotic diuretics cause V depletion and incr distal NaCl delivery -> hypokalemia
Ca inhibitor effects on K
acetazolamide causes V depletion (-> aldo) and incr distal Na delivery (w/ NaHCO3) and poorly resorbable anion (HCO3-) delivery -> hypokalemia
mannitol
osmotic diuresis
acetazolamide
CA inhibitors
furosemide
inhibits NKCC2 by substituting for chloride on transporter
how do most diuretics get into tubule?
most via tubular secretion rather than glomerular filtration (protein-bound)
mechs of “braking phenomenon”
neural (SNS), endocrine (RAAS), physical hypertrophy of unaffected nephron segments (chronic diuretic resistance)
conditions associated w/ decreased diuretic action (4)
bowel wall edema (no GI abs of drug); hypoalbuminemia (no proteins to bind drugs); ECV depletion (decr RPF); CKD
CA inhibitors lost from PT, lost in urine
lost from PT: bicarb, Na (b/c NaH has no gradient so Na not reabs), water; however, Na reabs in distal nephron, so instead lost in urine: bicarb, K (due to distal delivery of NaHCO3)
clinical use of CA inhibitors (4)
limited use as natriuretic; correction of metabolic alkalosis (be careful b/c alkalotic pts are already hypokalemic and CA inhibitor will worsen it); altitude sickness; glaucoma
loop diuretics lost in urine
chlorine, K, Na, water, Ca, Mg; these diuretics also block uric acid secretion so less uric acid lost; more water than Na lost (hypotonic urine -> can use to correct hyponatremia)
clinical use of loop diuretics (4)
correction of edematous disorders (CHF, pulm edema, nephrotic syndrome, renal failure); hyperkalemia; hypercalcemia; severe HTN (rarely used due to short half life)
loop vs thiazide half life
thiazide longer half life (better to tx HTN, more likely to cause kaliuresis)
loop diuretic side effects (7)
hypokalemia, hypocalcemia, hypercalcuria (stones), hypomagnesemia, hyperuricemia (block uric acid secretion), ototoxicity (usually reversible, worse w/ ethacrynic acid, b/c NKCC also in ear), sulfa allergy (use ethacrynic acid b/c no sulfa group)
ethacrynic acid
loop diuretic used for ppl w/ sulfa allergies, has side effect of ototoxicity (so don’t use unless severe sulfa allergy)
thiazide diuretics: onset of action timeline, natriuretic effect timeline, potency, effects on ions (Na, Cl, Ca, K, Mg)
onset of action 2-3 hrs, natriuretic effect < 6 hrs; less potent than loop diuretics b/c less Na reabs in DCT: loss of NaCl in urine (through NCC), increased calcium reabs (used to prevent stones and tx hypercalcuria), and loss of K and Mg in urine